The postentry restriction of HIV-1 replication in monocytes can be relieved when they differentiate to dendritic cells (DCs) or macrophages. Multiple mechanisms have been proposed to interpret the differentiation-dependent susceptibility of monocytes to HIV-1 infection, and the absence of host-cell-encoded essential factors for HIV-1 completing the life cycle may provide an explanation. We have analyzed the gene expression profile in monocytes by mRNA microarray and compared it with that of differentiated DCs. We demonstrated that purine-rich element binding protein ␣ (Pur-␣), a host-cell-encoded ubiquitous, sequence-specific DNA-and RNA-binding protein, showed inadequate expression in monocytes, and the translation of Pur-␣ mRNA was repressed by cellexpressed microRNA (miRNA). These Pur-␣-targeted miRNAs modulated the differentiation-dependent susceptibility of monocytes/DCs to HIV-1 infection, because rescue of Pur-␣ expression by transfection of miRNA inhibitors relieved the restriction of HIV-1 infection in monocytes, and ectopic input of miRNA mimics significantly reduced HIV-1 infection of monocyte-derived DCs (MDDCs). Collectively, our data emphasized that inadequate host factors contribute to HIV-1 restriction in monocytes, and cellular miRNAs modulate differentiation-dependent susceptibility of host cells to HIV-1 infection. Elaboration of HIV-1 restriction in host cells facilitates our understanding of viral pathogenesis and the search for a new antiviral
Monocytes are pivotal cells in the host immune system because they replenish dendritic cells (DCs) and macrophages to elicit an immune response against invading pathogens. Monocytes have been implicated in HIV-1 latency as a viral reservoir during highly active antiretroviral therapy (1) (2) (3) (4) (5) (6) (7) (8) (9) , indicating the vital role of monocytes in viral pathogenesis (10, 11) . Although primary monocytes express HIV-1 receptors and coreceptors, they are highly refractory for HIV-1 replication, and the restriction can be partially overcome when differentiated into DCs or macrophages (10, (12) (13) (14) .
Multiple mechanisms have been described to interpret the replication restriction of HIV-1 in undifferentiated monocytes (13) (14) (15) (16) (17) (18) (19) , and the restriction has been reflected in the multiple inefficiencies in the postentry steps of the HIV-1 life cycle, including reverse transcription, integration, and transcription (13, 16 -18) . The low expression of thymidine phosphorylase associated with a limited stock of deoxythymidine triphosphate has been shown to reduce HIV-1 reverse transcription (12) , and microRNA (miRNA)-198-mediated inadequate expression of cyclin T1, a crucial cellular cofactor of positive transcription elongation factor b, inhibits HIV-1 Tat transactivation in monocytes (20) .
Host-restrictive factor SAM domain HD domain-containing protein 1 (SAMHD1) has recently been shown to inhibit HIV-1 replication in myeloid cells and macrophages (21) (22) (23) (24) . SAMHD1 also protects primary
CD14
ϩ monocytes from HIV-1 infection, as the SAMHD1-deficient CD14 ϩ cells from individuals with Aicardi-Goutières syndrome are highly susceptible to HIV-1 infection (25) , while SAMHD1 shows equivalent expression in monocytes compared with their differentiated DC counterparts (21) , which suggests that SAMHD1 may not participate in modulation of differentiation-dependent restriction of monocytes to HIV-1 infection.
HIV-1 highly depends on host-cell-encoded factors to complete its life cycle (26 -32) . The absence of these essential host factors undoubtedly can lead to replication inefficiency in monocytes. Hundreds of HIV-1-dependent factors (HDFs) have been recently revealed by genome-wide RNA interference in engineered HeLa or HEK293 cells (27) (28) (29) . Affinity tagging and purification mass spectrometry have recently uncovered 497 HIV-human protein-protein interactions involving 435 individual human proteins in HEK293 and Jurkat human cell lines (33) . This has facilitated a more comprehensive and detailed understanding of how the host machinery is manipulated during the course of HIV-1 infection (33) . Although these HDFs have not been well characterized in monocytes, we have analyzed the gene expression profile in monocytes by mRNA microarray and compared it with that of their differentiated DCs. We found that several HDFs had been repressed by abundantly expressed cellular miRNAs for inadequate expression in monocytes, which may account for the recessive restriction of HIV-1 replication.
Among the above proteins, purine-rich element binding protein ␣ (Pur-␣) is a sequence-specific DNAand RNA-binding protein that is highly conserved in eukaryotic cells. Pur-␣ has multiple cellular functions, including participating in transcription, translation, and cell growth (34) . Notably, Pur-␣ has been shown to modulate HIV-1 replication by binding the HIV-1 TAR RNA element to enhance virus transcription (35) (36) (37) (38) . In the present study, we showed that Pur-␣ was inadequately expressed in monocytes, and translation of Pur-␣ mRNA was repressed by more highly expressed cellular miRNAs. The cellular Pur-␣-targeted miRNAs modulated the differentiation-dependent susceptibility of monocytes to HIV-1 infection. Our data confirm that inadequate host factors contribute to HIV-1 restriction in monocytes, and cellular miRNAs modulate differentiation-dependent susceptibility of host cells to HIV-1 infection.
MATERIALS AND METHODS

Cells
Human peripheral blood mononuclear cells (PBMCs) from healthy donors were purchased from the Blood Center of Shanghai (Shanghai, China). CD14 ϩ monocytes were purified from PBMCs using magnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) as described previously (39) . Monocytes were further stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-4 (IL-4) for 6 d to generate monocyte-derived dendritic cells (MDDCs). The HEK293T cell line was a kind gift from Dr. Li Wu (The Ohio State University, Columbus, OH, USA) and Dr. Vineet Kewal Ramani (National Cancer Institute, U.S. National Institutes of Health, Bethesda, MD, USA). HeLa-cellderived Magi/CCR5 cells and TZMB-L cells were gifts from Dr. Paul Zhou (Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China).
Flow cytometry
The purity and phenotype of generated MDDCs was assessed by flow cytometry, and monoclonal antibodies against the following human molecules were used for staining (clone numbers and resources are given in parentheses): phycoerythrin (PE)-conjugated CD3 (UCHT1; eBioscience, San Diego, CA, USA); APC-Alexa Fluor750-CD11c (B-ly6; BD Biosciences Pharmingen, San Diego, CA, USA); PE-CD14 (61D3; eBioscience); PE-CD19 (H1B19; eBioscience); PE-CD83 (HB15e; e-Bioscience); PE-CD86 (IT2.2; eBioscience); PE-DC-SIGN (eBh209; eBioscience); and APC-cy7-HLA-DR (LN3; eBioscience). MDDC viability was evaluated with a dead cell apoptosis kit with Annexin V Alexa Fluor 488 and PI (Invitrogen, Carlsbad, CA, USA). Stained cells were detected with an LSRII flow cytometer (BD Biosciences Pharmingen) and analyzed with FlowJo 7.6.1 software (TreeStar Inc., Ashland, OR, USA).
Virus stock
Calcium-phosphate-mediated transfection of HEK293T cells was used to generate virus stock as described previously (13) . Pseudotyped single-cycle HIV-Luc/VSV-G was cotransfected with the plasmid pLAI-⌬-env-Luc and expression plasmid of vesicular stomatitis virus G (VSV-G) protein, and replication competent HIV-1-AD8 (R5 tropic) virus was transfected with pNLAD8 of HIV-1 proviral vector. Plasmids were kind gifts from Li Wu (The Ohio State University). Harvested supernatants of transfected cells that contained viral particles were filtered and titrated with p24 gag capture ELISA.
HIV-1 infection assays
Cells were incubated with HIV-Luc/VSV-G (1 ng p24 gag ) or wild-type HIV-1-AD8 (1 ng p24 gag ) for 2 h, and after washing, cells were further cultured for 5 d (for HIV-Luc/VSV-G) and 4 or 6 d (for HIV-1-AD8). Viral infection was detected by measuring the luciferase activity from cell lysates, by p24 gag capture ELISA, or by real-time PCR for quantifying viral replication products. For the PCR, total cellular RNA was extracted with QIAamp RNeasy Mini Kit (Qiagen, Valencia, CA, USA), and the HIV-1 transcripts products of unspliced RNA (gag), singly spliced RNA (vpu), and multiply spliced RNA (tat-rev) were separately quantified and normalized with ␤-actin, and the relative expression was calculated. The primers used are listed in Supplemental Table S1 .
miRNA and mRNA microarrays analysis and quantification
The mRNA and miRNA expression profiles during monocyte to DC differentiation were screened with Affymetrix U133 plus 2.0 array and Agilent miRNA expression array (Shanghai Biochip Co., Shanghai, China), respectively. Genes were analyzed further online with the functional annotation tool in DAVID Bioinformatics Resources 6.7 (National Institute of Allergy and Infectious Diseases, U.S. National Instutes of Health, Bethesda, MD, USA). Target prediction of miRNAs and the alignments of miRNAs with target sequences were done using TargetScan (http://www.targetscan.org). The expression of miRNAs was verified with Bulge-loop miRNA qRT-PCR Primer Sets (RiboBio Corp, Guangzhou, China). The expression was adjusted based on U6 small nuclear RNA transcription, and relative miRNA expression of indicated controls was calculated. PCR was performed on the ABI 7900HT Real-Time PCR system (Applied Biosystems, Foster City, CA, USA).
Constructs and dual luciferase reporter assay
Pur-␣ 3=-UTR was amplified by PCR from the total RNA extracted from the Maji-CCR5 cell line. Primers for Pur-␣ 3=-UTR were as follows: 5=-CGGGGTACCGACAGTTTCTCTTCT-TGACTTGCCACCCATCGCTGG (forward); 5=-CCGCTCGAGC-ACTCAAAGATGATAGTCATGCAGCAGTTTAATGAT (reverse) or 5=-CCGCTCGAGCCAAATGAAGTATATGTCTTCTTTAGGC-AGGGGTT (reverse). Two PCR fragments containing different lengths of Pur-␣ 3=-UTR were excised with KpnI and XhoI and cloned into pGL3cM, and these two constructs were designated pGL3cM/Pur-␣ 3=-UTR 171-1560 and pGL3cM/Pur-␣ 3=-UTR 171-3782. Point mutations of conserved binding positions of Pur-␣ 3=-UTR for miRNAs were also constructed by using overlap PCR. Constructs were confirmed by restriction enzyme digestion and DNA sequencing. Plasmid pGL3cM was a kind gift from Dr. Ke Lan (Institute Pasteur of Shanghai).
A Dual-Luciferase Reporter Assay System (Promega, Madison, WI, USA) was used to examine the effects of miRNAs on their target genes as described previously (40) . Each miRNA or negative miRNA mimic was cotransfected into HEK293 cells with pRL-SV40 (2 ng) and pGL3cM/Pur-␣ 3=-UTR 171-1560 or pGL3cM/Pur-␣ 3=-UTR 171-3782 (50 ng). Lipofectamine 2000 (Invitrogen) was used for transfection. Cells were harvested for luciferase assay 48 h post-transfection. Cells were washed with PBS and homogenized with 100 l Passive Lysis Buffer (Promega); lysate (15 l) was added with Luciferase Assay Buffer (30 l) and mixed; and firefly luciferase activity was measured on a Veritas luminometer (Turner BioSystems, Sunnyvale, CA, USA), The plate was removed from the luminometer and Stop & Glo Reagent (30 l) was added and mixed. Renilla luciferase activity was measured on the luminometer. The data recorded on the luminometer were analyzed and the relative readouts were calculated.
Transfection of siRNA, miRNA inhibitors and mimics, or plasmids
Lipofectamine 2000 (Invitrogen) was used for transfection according to the manufacturer's instructions. Cells were transfected with specific duplex siRNA of Pur-␣ or off-target control (GenePharma, Shanghai, China), or with miRNA inhibitors or mimics (GenePharma), or with plasmid of pcDNA3.1 or pcDNA3.1/Pur-␣. After the indicated time, cells were harvested either for Western blotting to verify gene expression, or for viral infection as described above. The sequences of siRNA duplex, miRNA inhibitors and mimics, and negative controls are listed in Supplemental Table S1 . For Western blotting, purified anti-Pur-␣ monoclonal antibody (3A9; Sigma-Aldrich, St. Louis, MO, USA) or anti-␣-tubulin monoclonal antibody (B-5-1-2; Sigma-Aldrich) were used as primary antibodies, and horseradish-peroxidase-conjugated goat anti-mouse IgG (Sigma-Aldrich) was used as secondary antibody. Gray density of gel was analyzed with the plugs-in of ImageJ software (U.S. National Institutes of Health).
HIV-1 long terminal repeat (LTR)-promoted luciferase assay
TZMB-L cells containing an HIV-1-LTR-luciferase were transfected with plasmid pCMV-Tat (a gift from Dr. Li Wu, The Ohio State University), with or without pcDNA3.1, containing or not Pur-␣ gene. At 48 h post-transfection, cells were harvested for luciferase assay as above.
Statistical analysis
Statistical analysis was performed using a paired t test with SigmaStat 2.0 (Systat Software, San Jose, CA, USA).
RESULTS
Pur-␣ enhances Tat-responsive transcription and is essential for HIV-1 infection
Pur-␣ has been demonstrated to participate in Tat activation of viral genes (34, 35) . The GA/GC-rich motif upstream from the LTR-promoter sequence provides a binding site for Pur-␣ and recruits Tat, cyclin T1 and cdk9 in proximity to the transcription start site, which then leads to phosphorylation of the C-terminal domain of RNA polymerase II and acceleration of transcription. Here, we confirmed enhancement of Pur-␣ in Tat-responsive transcription in TZMB-L cells containing an HIV-1-LTR-luciferase. The exogenous expression of Pur-␣ accelerated significantly the Tatresponsive, HIV-1-LTR-promoted, luciferase expression (Fig. 1A) .
To demonstrate the essential role of endogenous expression of Pur-␣ for efficient HIV-1 transcription, we successively knocked down the expression of Pur-␣ in MDDCs with specific siRNA1 and siRNA2 interference, as detected by Western blotting (Fig.  1B) . Expectedly, the knockdown of Pur-␣ significantly inhibited the replication of HIV-luc/VSV-G and replication-competent HIV-1/AD8 (Fig. 1C) . Accordingly, HIV-1 transcripts or post-transcriptional products were shown to be diminished by quantification of RNA for gag, tat-rev, and vpu, respectively (Fig. 1D ). MDDCs were generated from CD14 (Fig. 1E ). These MDDCs maintained Ͼ 91% viability by testing with dead cell apoptosis kit with Annexin V Alexa Fluor 488 and PI (Fig. 1E ). This approach of siRNA-specific interference has been performed in HeLa-cell-derived Magi/CCR5 cells. Similarly, knockdown of Pur-␣ significantly inhibited viral replication and diminished the viral transcripts or post-transcriptional products (Supplemental Fig. S1 ). Together, the results confirm that Pur-␣ expression is essential for efficient HIV-1 transcription. 
Inadequate expression of Pur-␣ contributes to inefficiency of HIV-1 infection in undifferentiated monocytes
Monocytes are highly refractory for HIV-1 replication. We confirmed using VSV-G-pseudotyped single-cycle infectious virus, HIV-luc/VSV-G, that viral infection in monocytes was dramatically inhibited, and the restriction could be partially overcome when monocytes were differentiated into MDDCs on stimulation with GM-CSF and IL-4 ( Fig. 2A) . Diminished viral transcription in monocytes compared with MDDCs was observed by quantifying the transcriptional products of HIV-1 gag mRNA (Fig. 2B) . We aimed to establish whether Pur-␣ participated in modulation of differentiation-dependent susceptibility of monocytes/MDDCs to HIV-1 infection. Compared with differentiated MDDCs, monocytes showed a 42% decrease in mRNA production and a 76% decrease in protein translation (Fig. 2C) , indicating that both transcription and translation of Pur-␣ gene were repressed in monocytes.
To investigate whether exogenous expression of Pur-␣ rescued HIV-1 infection in monocytes, we transfected monocytes with a Pur-␣-gene-containing plasmid, pcDNA 3.1/Pur-␣, and protein expression was confirmed by Western blotting (Fig. 2D) . When HIV-Luc/VSV-G was used for infection, as expected, exogenous expression of Pur-␣ significantly rescued viral infection in monocytes (Fig. 2E) . Transfection with plasmids did not affect the differentiation of monocytes to MDDCs on stimulation with GM-CSF and IL-4, as monitored by the comparable DC-SIGN level between the groups (data not shown). Together, these data suggest that insufficient expression of Pur-␣ contributes to the inefficiency of HIV-1 infection in undifferentiated monocytes. 
Monocytes contain high levels of miRNAs that target Pur-␣
To examine the mechanism of suppression of Pur-␣ expression in monocytes, we investigated the expression profiles of miRNAs in monocytes. The altered miRNAs expressed in monocytes and their MDDC counterparts from Agilent miRNA expression array are listed in Supplemental Table S2 . Target prediction of miRNAs was done using online software TargetScan. The sequences and alignments of miRNAs with the 3=-UTR of Pur-␣ mRNA are shown in Fig. 3A . miR-15a, miR-15b, and miR-16 showed higher PhastCons and mirSVR scores ( Table 1) . PhastCons score was used to measure the conservation of target nucleotide positions, and mirSVR scoring is a regression method for predicting likelihood of target mRNA down-regulation from sequence and structure features in miRNA/ mRNA-predicted target sites. The relative expression calculated from miRNA expression array (Fig. 3B) was checked with Bulge-loop miRNA RT-PCR quantification (Fig. 3C) . Together, these data show that the translation of Pur-␣ mRNA may be repressed miRNAs that enriched in undifferentiated monocytes.
Pur-␣ mRNA 3=-UTR was targeted by miRNAs in reporter system
To confirm the targeting of Pur-␣ mRNA 3=-UTR by miRNAs, 3=-UTR fragments of Pur-␣ mRNA were cloned into pGL3cM. The shorter length of the 3=-UTR fragment (pGL3cM/Pur-␣ 3=-UTR 171-1560) contained the conserved binding positions for all six tested miRNAs and (Fig. 4A) .
Mutations were introduced at the conserved binding positions of Pur-␣ 3=-UTR to reduce Watson-Crick base pairing with miRNAs. Two mutants were constructed in the plasmid of GL3cM/Pur-␣ 3=-UTR 171-1560: mutant 1 contained the point mutations of conserved binding positions for miR-15a, miR-15b and miR-16; and mutant 2 contained the point mutations of conserved binding positions for miR-20a, miR-93, and miR-106b (Fig. 4B) . The inhibition of transfected miRNA mimics on expression of pGL3cM containing 3=-UTR fragments of Pur-␣ or mutants was quantified using a dual-luciferase reporter assay system, and the relative activity of firefly and Renilla luciferases was calculated. Transfection with miRNA mimics significantly inhibited expression of pGL3cM/Pur-␣ 3=-UTR 171-1560 and pGL3cM/Pur-␣ 3=-UTR 171-3782 (Fig. 4C, D) , and the mutation of conserved binding positions abolished the inhibition mediated by miRNA mimics (Fig. 4C) . Together, these data demonstrated that miR-15a, miR-15b, miR-16, miR-20a, miR-106b, and miR-93 could target Pur-␣ mRNA 3=-UTR for repression.
miRNAs targeting Pur-␣ modulate HIV-1 infection in undifferentiated monocytes
To investigate whether these highly expressed miRNAs that target Pur-␣ in monocytes modulated susceptibility to HIV-1 infection, we transfected monocytes separately with chemically synthesized, single-stranded miRNA inhibitors. The translation of Pur-␣ was up-regulated, as detected by Western blotting and then calculated by gel density analysis (Fig. 5A) . Notably, the transfection of miRNA inhibitors significantly, although modestly for individual evaluation, promoted the infection of monocytes by HIV-Luc/VSV-G (Fig. 5B, C) . Besides the fine regulation by miRNAs, it is possible that other host restrictions are also involved in blocking HIV-1 infection in monocytes. On the contrary, when the chemically synthesized miRNA mimics were transfected into MDDCs, translation of Pur-␣ mRNA was suppressed (Fig. 5D) , and infection of MDDCs by HIV-Luc/VSV-G was accordingly significantly diminished (Fig. 5E, F) . Taken together, these data demonstrate that miRNAmediated regulation of expression of Pur-␣ contributes to modulation of the differentiation-dependent susceptibility of monocytes and MDDCs to HIV-1 infection. interference or affinity tagging and purification mass spectrometry have been used to identify host genes or virus-interacting proteins involved in viral replication. Hundreds of host genes or proteins have been identified, despite the wide difference in selected candidates (16, 27, 29, 33) . Cell lines or non-natural biological targets of HIV-1 were uniformly chosen in all of these large-scale surveys; it appears interesting if primary cells were used to confirm these results. The gene expression profile in monocytes by mRNA microarray was hence analyzed and compared with that of their differentiated DCs. Focusing on the inadequately expressed genes helps to interpret the recessive restriction of HIV-1 in undifferentiated monocytes. Besides Pur-␣, the representative for analysis here, it would be interesting to expand more host gene candidates for elucidation of viral restriction in monocytes.
DISCUSSION
The miRNA-mediated modulation of HDFs provides a new insight into understanding the differentiationdependent susceptibility to HIV-1 infection in monocytes and DCs. Besides Pur-␣ mRNA, the translation of cyclin T1, a key host factor required for Tat-derived HIV-1 transcription, also has been reported to be inhibited by cellular miR-198 (20) ; thus, impaired HIV-1 transcription occurs in undifferentiated monocytes. Other miRNAs, such as miR-28, miR-150, miR-223, and miR-382, have been demonstrated to correlate with susceptibility of monocytes and macrophages to HIV-1 infection, because transfection with these miRNA inhibitors or mimics can modulate HIV-1 infection in monocytes and macrophages (42) . miRNAs have been reported to silence HIV-1 replication by directly targeting viral sequences. Enriched expression of cellular miR-28, miR-125b, miR-150, miR-223, and miR-382 in resting CD4
ϩ T lymphocytes can render HIV-1 productive infection into latency by directly targeting 3=-UTR of HIV-1 transcripts for repression (43) .
The host-encoded proteins on which HIV-1 is highly dependent for replication are ideal, potentially longlasting targets for antiviral drugs or gene therapy for blocking HIV-1 infection. CCR5, a protein on CD4 cells that HIV needs for entry, is targeted by the drug maraviroc for blocking viral entry. Many host factors that could render MDDCs susceptible to HIV-1 infection have been screened, although the association with HIV-1 infection needs verification in vitro and in vivo. Considering the portal location and pivotal roles of DCs during HIV-1 primary infection and viral dissemination, interference with expression by certain host factors, such as Pur-␣ or cyclin T1, could be a candidate approach for prevention of HIV-1 from primary infection.
